MapLight Therapeutics, Inc.

Report date
6/30/2026
Quarter
2026 Q2
Filed
8/14/2026
Shares
950,011
Value ($000)
34,048
Weight
11.8%
2025 Q4 - 2026 Q2 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).